199 related articles for article (PubMed ID: 25337697)
1. Analysis of gene expression in induced pluripotent stem cell-derived human neurons exposed to botulinum neurotoxin A subtype 1 and a type A atoxic derivative.
Scherf JM; Hu XS; Tepp WH; Ichtchenko K; Johnson EA; Pellett S
PLoS One; 2014; 9(10):e111238. PubMed ID: 25337697
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ELISA as endpoint in neuronal cell-based assay for BoNT detection using hiPSC derived neurons.
Pellett S; Tepp WH; Johnson EA; Sesardic D
J Pharmacol Toxicol Methods; 2017 Nov; 88(Pt 1):1-6. PubMed ID: 28465161
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6.
Moritz MS; Tepp WH; Bradshaw M; Johnson EA; Pellett S
mSphere; 2018 Oct; 3(5):. PubMed ID: 30355669
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Neurotoxins Can Enter Cultured Neurons Independent of Synaptic Vesicle Recycling.
Pellett S; Tepp WH; Scherf JM; Johnson EA
PLoS One; 2015; 10(7):e0133737. PubMed ID: 26207366
[TBL] [Abstract][Full Text] [Related]
5. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.
Pier CL; Chen C; Tepp WH; Lin G; Janda KD; Barbieri JT; Pellett S; Johnson EA
FEBS Lett; 2011 Jan; 585(1):199-206. PubMed ID: 21126520
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of differentially regulated genes in human neuronal and epithelial cell lines upon exposure to type A botulinum neurotoxin.
Thirunavukkarasusx N; Ghosal KJ; Kukreja R; Zhou Y; Dombkowski A; Cai S; Singh BR
Biochem Biophys Res Commun; 2011 Feb; 405(4):684-90. PubMed ID: 21291863
[TBL] [Abstract][Full Text] [Related]
7. Substrate cleavage and duration of action of botulinum neurotoxin type FA ("H, HA").
Pellett S; Tepp WH; Lin G; Johnson EA
Toxicon; 2018 Jun; 147():38-46. PubMed ID: 29273248
[TBL] [Abstract][Full Text] [Related]
8. Activity of botulinum neurotoxin type D (strain 1873) in human neurons.
Pellett S; Tepp WH; Scherf JM; Pier CL; Johnson EA
Toxicon; 2015 Jul; 101():63-9. PubMed ID: 25937339
[TBL] [Abstract][Full Text] [Related]
9. Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.
Whitemarsh RC; Tepp WH; Bradshaw M; Lin G; Pier CL; Scherf JM; Johnson EA; Pellett S
Infect Immun; 2013 Oct; 81(10):3894-902. PubMed ID: 23918782
[TBL] [Abstract][Full Text] [Related]
10. Atoxic derivative of botulinum neurotoxin A as a prototype molecular vehicle for targeted delivery to the neuronal cytoplasm.
Vazquez-Cintron EJ; Vakulenko M; Band PA; Stanker LH; Johnson EA; Ichtchenko K
PLoS One; 2014; 9(1):e85517. PubMed ID: 24465585
[TBL] [Abstract][Full Text] [Related]
11. Human Induced Pluripotent Stem Cell Derived Neuronal Cells Cultured on Chemically-Defined Hydrogels for Sensitive In Vitro Detection of Botulinum Neurotoxin.
Pellett S; Schwartz MP; Tepp WH; Josephson R; Scherf JM; Pier CL; Thomson JA; Murphy WL; Johnson EA
Sci Rep; 2015 Sep; 5():14566. PubMed ID: 26411797
[TBL] [Abstract][Full Text] [Related]
12. Persistence of botulinum neurotoxin a subtypes 1-5 in primary rat spinal cord cells.
Whitemarsh RC; Tepp WH; Johnson EA; Pellett S
PLoS One; 2014; 9(2):e90252. PubMed ID: 24587301
[TBL] [Abstract][Full Text] [Related]
13. Novel application of human neurons derived from induced pluripotent stem cells for highly sensitive botulinum neurotoxin detection.
Whitemarsh RC; Strathman MJ; Chase LG; Stankewicz C; Tepp WH; Johnson EA; Pellett S
Toxicol Sci; 2012 Apr; 126(2):426-35. PubMed ID: 22223483
[TBL] [Abstract][Full Text] [Related]
14. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
Pellett S; Tepp WH; Bradshaw M; Kalb SR; Dykes JK; Lin G; Nawrocki EM; Pier CL; Barr JR; Maslanka SE; Johnson EA
mSphere; 2016; 1(1):. PubMed ID: 27303710
[TBL] [Abstract][Full Text] [Related]
15. Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a.
Wang T; Martin S; Papadopulos A; Harper CB; Mavlyutov TA; Niranjan D; Glass NR; Cooper-White JJ; Sibarita JB; Choquet D; Davletov B; Meunier FA
J Neurosci; 2015 Apr; 35(15):6179-94. PubMed ID: 25878289
[TBL] [Abstract][Full Text] [Related]
16. Enhancing toxin-based vaccines against botulism.
Przedpelski A; Tepp WH; Zuverink M; Johnson EA; Pellet S; Barbieri JT
Vaccine; 2018 Feb; 36(6):827-832. PubMed ID: 29307477
[TBL] [Abstract][Full Text] [Related]
17. Neuronal targeting, internalization, and biological activity of a recombinant atoxic derivative of botulinum neurotoxin A.
Pellett S; Tepp WH; Stanker LH; Band PA; Johnson EA; Ichtchenko K
Biochem Biophys Res Commun; 2011 Feb; 405(4):673-7. PubMed ID: 21284937
[TBL] [Abstract][Full Text] [Related]
18. Holotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.
Bradshaw M; Tepp WH; Whitemarsh RC; Pellett S; Johnson EA
Appl Environ Microbiol; 2014 Dec; 80(23):7415-22. PubMed ID: 25239905
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.
Foran PG; Mohammed N; Lisk GO; Nagwaney S; Lawrence GW; Johnson E; Smith L; Aoki KR; Dolly JO
J Biol Chem; 2003 Jan; 278(2):1363-71. PubMed ID: 12381720
[TBL] [Abstract][Full Text] [Related]
20. Translocation domain of botulinum neurotoxin A subtype 2 potently induces entry into neuronal cells.
Kohda T; Tsukamoto K; Torii Y; Kozaki S; Mukamoto M
Microbiol Immunol; 2020 Jul; 64(7):502-511. PubMed ID: 32301520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
